Skip Navigation



JAC Advance Access published online on June 12, 2003

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg305
© 2003 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/1/113    most recent
dkg305v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Werner, G.
Right arrow Articles by Witte, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Werner, G.
Right arrow Articles by Witte, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The British Society for Antimicrobial Chemotherapy

Brief report

Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital

Guido Werner 1 *, Ingo Klare 1 , Friedrich-Bernhard Spencker 2 , and Wolfgang Witte 1

1 Robert Koch Institute, Wernigerode Branch, Burgstr. 37, 38855 Wernigerode
2 Institute of Medical Microbiology and Epidemiology of Infectious Diseases, University Leipzig, Liebigstraße 24, 04103 Leipzig, Germany

* Corresponding author. E-mail: wernerg{at}rki.de.

Received 20 February 2003 ; revised 28 April 2003 ; accepted 28 April 2003

Abstract

Objectives: To demonstrate nosocomial transmission of Enterococcus faecium resistant to quinupristin/dalfopristin and vancomycin/teicoplanin among paediatric patients in a German hospital ward.

Materials and methods: Multiply-resistant E. faecium were isolated from three female patients aged 9 months, 2 and 15 years during a 10 day time span. Antibiotic susceptibilities were determined by microbroth dilution. Clonal relatedness among the isolates was investigated via SmaI-macrorestriction analysis by PFGE, multilocus sequence typing (MLST), and plasmid profiling. Presence of virulence and resistance determinants was tested by polymerase chain reaction (PCR). Selected resistance genes were localized by Southern hybridizations.

Results: A single E. faecium isolate per patient was investigated. All exhibited resistances to quinupristin/dalfopristin, vancomycin/teicoplanin, streptomycin (high-level), penicillin/ampicillin, erythromycin, oxytetracycline, chloramphenicol, rifampicin and fusidic acid. The isolates were susceptible to linezolid only and intermediately resistant to fluoroquinolones including moxifloxacin. PFGE revealed identical patterns for all three isolates. PCRs for virulence determinants hyaluronidase and enterococcal surface protein, esp, were negative, whereas PCR for the enterocin A gene was positive. MLST identified clonal type [8-5-1-1-1-1-1] belonging to a clonal subgroup C1 of hospital- and outbreak-related E. faecium. Southern hybridizations located several resistance genes (erm(B), vat(D), vanA) on a large plasmid, which was transferable in mating experiments with an E. faecium recipient.

Conclusions: These data show routes of dissemination of resistance to multiple antibiotics including streptogramins and glycopeptides in E. faecium via vertical and/or horizontal gene transfer. The isolates spread in the absence of a direct selective pressure, as none of the patients had received earlier streptogramin or glycopeptide therapy.

Keywords: quinupristin/dalfopristin, vancomycin, vanA, vat(D), VRE
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
M. Abele-Horn, U. Vogel, I. Klare, C. Konstabel, R. Trabold, R. Kurihara, W. Witte, W. Kreth, P.-G. Schlegel, and H. Claus
Molecular Epidemiology of Hospital-Acquired Vancomycin-Resistant Enterococci
J. Clin. Microbiol., November 1, 2006; 44(11): 4009 - 4013.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
L. Stampone, M. Del Grosso, D. Boccia, and A. Pantosti
Clonal Spread of a Vancomycin-Resistant Enterococcus faecium Strain among Bloodstream-Infecting Isolates in Italy
J. Clin. Microbiol., April 1, 2005; 43(4): 1575 - 1580.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
Z. Bersos, M. Maniati, F. Kontos, E. Petinaki, and A. N. Maniatis
First report of a linezolid-resistant vancomycin-resistant Enterococcus faecium strain in Greece
J. Antimicrob. Chemother., April 1, 2004; 53(4): 685 - 686.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.